Table 4.
Prognostic factors | Hazard ratio (95% CI) | P value |
---|---|---|
Prognostic groups by score | ||
Indolent (score: 0–1) | 1 (reference) | |
Intermediate (score: 2) | 7.23 (1.75–29.79) | 0.00611 |
Aggressive (score: 3–4) | 28.49 (5.77–140.61) | < 0.0001 |
Age | 1.00 (0.96–1.05) | 0.972 |
Tumor type | ||
Functional | 1 (reference) | |
Nonfunctional | 0.762 (0.16–3.71) | 0.735 |
Tumor location | ||
Distal/body | 1 (reference) | |
Head | 0.60 (0.19–1.94) | 0.394 |
T-stage | ||
T1 | 1 (reference) | |
T2 | 1.55 (0.23–10.35) | 0.65 |
T3 | 2.17 (0.24–20.04) | 0.49 |
Lymphovascular invasion | ||
Absent | 1 (reference) | |
Present | 2.35 (0.88–6.27) | 0.0879 |
Perineural Invasion | ||
Absent | 1 (reference) | |
Present | 0.87 (0.24–3.10) | 0.826 |
MEN1 | ||
Absent | 1 (reference) | |
Present | 4.46 (0.33–60.13) | 0.260 |
Italic – p-value < 0.05